To the best of our knowledge, this study is the first multicentric effort to prospectively investigate the prevalence of HER2-neu overexpression in newly diagnosed early or metastatic GC patients residing in Lebanon specifically, as well as in Arab countries in general. This evidence concerns the gene ERBB2 and gastric cancer.